Our expertise
Eurofins CDMO takes pride in delivering cutting-edge solutions for the development and biomanufacturing of a diverse range of biologics, including antibodies, proteins, enzymes, live biotherapeutic products and various types of bacteria. All innovative products begin with proof-of-concept studies, and we offer small research scale productions to meet initial activity study needs. Our facilities are designed for scalability, ensuring seamless transition to larger batches while addressing potential regulatory challenges. We offer cost-efficient non-GMP batches without compromising on quality, thanks to the segregation in our facilities.
To learn more